InsidersTradesSigma
Follow the Orexigen Therapeutics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was reported on 4 February 2016 (Attribution). Among the most active insiders: Klassen Preston. Every trade is free.
Analysts rate Orexigen Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on developing treatments for obesity. It is listed on NASDAQ under the ticker OREX.